UK Drug Pricing Negotiations Collapse

Negotiations between the UK government and pharmaceutical companies over drug pricing have collapsed after the industry rejected proposals to increase discount rates.

The breakdown raises concerns about access to medicines and the competitiveness of the British healthcare market.